chr20-63361854-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000675470.1(CHRNA4):​c.-689G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 152,200 control chromosomes in the GnomAD database, including 2,603 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2602 hom., cov: 30)
Exomes 𝑓: 0.090 ( 1 hom. )

Consequence

CHRNA4
ENST00000675470.1 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.193

Publications

13 publications found
Variant links:
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
CHRNA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 20-63361854-C-T is Benign according to our data. Variant chr20-63361854-C-T is described in ClinVar as Benign. ClinVar VariationId is 1169561.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.558 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000675470.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LOC100130587
NR_110634.1
n.219C>T
non_coding_transcript_exon
Exon 2 of 5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
ENST00000463705.5
TSL:1
n.1032-10827G>A
intron
N/A
CHRNA4
ENST00000675470.1
c.-689G>A
5_prime_UTR
Exon 3 of 5ENSP00000502096.1A0A6Q8PG41
ENSG00000203900
ENST00000370257.1
TSL:2
n.219C>T
non_coding_transcript_exon
Exon 2 of 5

Frequencies

GnomAD3 genomes
AF:
0.167
AC:
25399
AN:
151982
Hom.:
2603
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.156
Gnomad AMI
AF:
0.220
Gnomad AMR
AF:
0.164
Gnomad ASJ
AF:
0.163
Gnomad EAS
AF:
0.575
Gnomad SAS
AF:
0.252
Gnomad FIN
AF:
0.160
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.137
Gnomad OTH
AF:
0.187
GnomAD4 exome
AF:
0.0900
AC:
9
AN:
100
Hom.:
1
Cov.:
0
AF XY:
0.0811
AC XY:
6
AN XY:
74
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.667
AC:
4
AN:
6
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12
Middle Eastern (MID)
AF:
0.500
AC:
1
AN:
2
European-Non Finnish (NFE)
AF:
0.0429
AC:
3
AN:
70
Other (OTH)
AF:
0.167
AC:
1
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.167
AC:
25411
AN:
152100
Hom.:
2602
Cov.:
30
AF XY:
0.171
AC XY:
12688
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.156
AC:
6492
AN:
41490
American (AMR)
AF:
0.164
AC:
2508
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.163
AC:
566
AN:
3472
East Asian (EAS)
AF:
0.575
AC:
2961
AN:
5146
South Asian (SAS)
AF:
0.251
AC:
1210
AN:
4822
European-Finnish (FIN)
AF:
0.160
AC:
1700
AN:
10600
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.137
AC:
9303
AN:
67960
Other (OTH)
AF:
0.185
AC:
390
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1088
2176
3264
4352
5440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.143
Hom.:
249
Bravo
AF:
0.169
Asia WGS
AF:
0.375
AC:
1301
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
10
DANN
Benign
0.91
PhyloP100
-0.19

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6122429; hg19: chr20-61993206; API